UK National Screening Committee
...recommended against screening for a number of other conditions. These included congenital adrenal hyperplasia (CAH) in newborns, glaucoma, hearing loss in older adults, mucopolysaccharidosis type I (MPS I), neuroblastoma in...
Watch Dr Anne Mackie, director of screening in Public Health England, reflecting on 2015, calling it "a particularly exciting year for screening". Please note that you can turn on subtitles for this video.
I must admit that I didn’t sleep very well last Tuesday. I was a little worried about the first UK National Screening Committee stakeholder conference (which I've been helping to organise) at the Oval conference centre the day after. Would …
...evidence from the piloting of human papillomavirus (HPV) primary screening by the cervical screening programme ongoing implementation of bowel scope screening that should save many lives expansion of newborn blood...
...programme. There is guidance in the document about how to go about this and the sort of high level evidence that the secretariat will need to be able to consider...
...three topics we’ve chosen are atrial fibrillation, expanded newborn blood spot screening and preterm labour. But don’t worry if you’re not involved in these areas as much of the information...
...seem that innovation moves slowly in the world of screening. But the UK National Screening Committee (UK NSC) is committed to evaluating emerging technologies as soon as it’s practical to...
The UK’s processes and standards for reviewing screening policy and making screening recommendations are recognised and respected as world leading.
...to so many people who have so many different perspectives on screening. It's helped out to refine our understanding and description of what distinguishes systematic population screening programmes from other...
...the governments of England, Northern Ireland, Scotland and Wales. Recommendations usually get published 6 weeks after each UK NSC meeting to give enough time for ministers in each country to...
